Single-nucleus RNA sequencing identifies cell-type–specific effects of sodium-glucose co-transporter 2 inhibitors in human myocardial slices-Reference-Cited by-同舟云学术

Single-nucleus RNA sequencing identifies cell-type–specific effects of sodium-glucose co-transporter 2 inhibitors in human myocardial slices

Published:2024-07-31 Issue:35 Volume:45 Page:3292-3295
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Schmidt Kevin¹²³^ORCID,Fuchs Maximilian²³,Weber Natalie¹⁴,Werlein Christopher⁵,Schmitto Jan D⁴⁶,Ius Fabio⁴⁶^ORCID,Ruhparwar Arjang⁴⁶,Bär Christian¹²³⁴,Fiedler Jan¹²³,Thum Thomas¹⁴^ORCID

Affiliation:

1. Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School , Carl-Neuberg-Str. 1, 30625 Hannover , Germany

2. Fraunhofer Institute for Toxicology and Experimental Medicine ITEM , Hannover , Germany

3. Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD) , Hannover , Germany

4. Center for Translational Regenerative Medicine, Hannover Medical School , Carl-Neuberg-Str. 1, 30625 Hannover , Germany

5. Institute of Pathology, Hannover Medical School , Hannover , Germany

6. Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School , Hannover , Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/eurheartj/article-pdf/45/35/3292/59118065/ehae472.pdf

Reference10 articles.

1. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC;McDonagh;Eur Heart J,2021

2. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC;McDonagh;Eur Heart J,2023

3. Implementation of sodium–glucose cotransporter 2 inhibitors for heart failure with reduced ejection fraction: where we are versus where we need to be;Pierce;Eur J Heart Fail,2023

4. Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2;Wu;Cell Rep Med,2023

5. Hypertrophic cardiomyopathy dysfunction mimicked in human engineered heart tissue and improved by sodium–glucose cotransporter 2 inhibitors;Wijnker;Cardiovasc Res,2024